Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States

Table 4 Frequency of complications (rate per 1000 person-months) in patients with GEC, by treatment regimen

Complication	5-FU monotherapy	Capecitabine monotherapy	5-FU combination therapy	Capecitabine combination therapy	Any 5-FU regimen	Any capecitabine regimen
Bone marrow	233	110	349	205	307	151
Constitutional symptom	254	108	323	295	293	183
Gastrointestinal tract symptoms	465	183	577	284	529	224
Infection	199	114	268	150	238	131
Skin complications	0	0	2	0	1	0
Other	14	14	22	32	19	22
Any complication	764	336	835	460	806	387